Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface.
暂无分享,去创建一个
M. Galésio | M. Sales | J. Noronha | M Goreti F Sales | M. Diniz | J. Costa-Rodrigues | Maria H Fernandes | T. S. Rebelo | João P Noronha | João Costa-Rodrigues | Tânia S C R Rebelo | Marco Galésio | Hugo Santos | Mário Diniz | M. Fernandes | Hugo Santos | M. Galesio | J.P. Noronha | M. Galésio | M. Goreti F. Sales | Maria H. Fernandes
[1] A. Schally,et al. Regulation of prostate‐specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone‐releasing hormone and vasoactive intestinal peptide , 2001, The Prostate.
[2] G. Bubley,et al. Biology of prostate-specific antigen. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Guilan Wang,et al. Preparation, characterization, and time-resolved fluorometric application of silica-coated terbium(III) fluorescent nanoparticles. , 2004, Analytical chemistry.
[4] Nuno M Reis,et al. Portable smartphone quantitation of prostate specific antigen (PSA) in a fluoropolymer microfluidic device. , 2015, Biosensors & bioelectronics.
[5] Yan Liu. Electrochemical detection of prostate-specific antigen based on gold colloids/alumina derived sol-gel film , 2008 .
[6] Mitsuru Nenoi,et al. Regulation of , 2004 .
[7] P. T. D. Oliveira,et al. Evaluation of in vitro human gingival fibroblast seeding on acellular dermal matrix. , 2010, Brazilian dental journal.
[8] J. Ferlay,et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.
[9] H. Beitollahi,et al. Electrocatalytic oxidation and determination of epinephrine in the presence of uric acid and folic acid at multiwalled carbon nanotubes/molybdenum(VI) complex modified carbon paste electrode , 2011 .
[10] Ian M Thompson,et al. Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker , 2004, Cancer.
[11] H. Santos,et al. An improved clean sonoreactor-based method for protein identification by mass spectrometry-based techniques , 2008 .
[12] I. Tothill,et al. Development of a sensitive detection method of cancer biomarkers in human serum (75%) using a quartz crystal microbalance sensor and nanoparticles amplification system. , 2010, Talanta.
[13] Thomas Laurell,et al. Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms. , 2010, Journal of proteomics.
[14] Xue Zhang,et al. A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor. , 2007, Biosensors & bioelectronics.
[15] A. Passaniti,et al. Regulation of prostate‐specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix , 1994, The Prostate.
[16] G. Prins,et al. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. , 1995, Endocrinology.
[17] Yong-Keun Lee,et al. Transformation of Electrodeposited Calcium Phosphate Coatings in Simulated Body Fluid and in Culture Medium , 2005 .
[18] E. Feinstein,et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53 , 2002, Oncogene.
[19] A. Partin,et al. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. , 1998, Critical reviews in clinical laboratory sciences.
[20] M. T. Santini,et al. Three-dimensional cell organization leads to a different type of ionizing radiation-induced cell death: MG-63 monolayer cells undergo mitotic catastrophe while spheroids die of apoptosis. , 2007, International journal of oncology.
[21] S. Milz,et al. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. , 2004, Anticancer research.
[22] Joseph D. Gong,et al. Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers. , 2006, Journal of the American Chemical Society.
[23] W. S. Hummers,et al. Preparation of Graphitic Oxide , 1958 .
[24] A. Akbari,et al. Electrochemical behavior of a carbon paste electrode modified with 5-amino-3′,4′-dimethyl-biphenyl-2-ol/carbon nanotube and its application for simultaneous determination of isoproterenol, acetaminophen and N-acetylcysteine , 2012 .
[25] S. Olayat,et al. Advances in Brief Molecular Cloning and Expression of an Alternative hKLK 3 Transcript Coding for a Variant Protein of Prostate-specific Antigen 1 , 1999 .
[26] Ming Zhao,et al. Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array. , 2011, Biosensors & bioelectronics.
[27] M. Goreti F. Sales,et al. Novel Potentiometric Sensors of Molecular Imprinted Polymers for Specific Binding of Chlormequat , 2008 .
[28] K. Fujikawa,et al. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. , 2001, Biochemistry.
[29] N Heuzé,et al. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. , 1999, Cancer research.
[30] M. Goreti F. Sales,et al. Novel Prostate Specific Antigen plastic antibody designed with charged binding sites for an improved protein binding and its application in a biosensor of potentiometric transduction , 2014 .
[31] Agustín Costa-García,et al. Simultaneous detection of free and total prostate specific antigen on a screen-printed electrochemical dual sensor. , 2009, Biosensors & bioelectronics.
[32] M. Essand,et al. Characterization of human prostate and breast cancer cell lines for experimental T cell‐based immunotherapy , 2007, The Prostate.
[33] R. Dhir,et al. Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma , 2007, Diagnostic pathology.
[34] J. Capelo,et al. Ultra fast trypsin digestion of proteins by high intensity focused ultrasound. , 2005, Journal of proteome research.
[35] W. Goessler,et al. Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation , 2006, BMC Cancer.
[36] Niina J. Ronkainen,et al. Electrochemical biosensors. , 2010, Chemical Society reviews.
[37] S. Reed,et al. Prostein expression is highly restricted to normal and malignant prostate tissues , 2004, The Prostate.
[38] M. Mason,et al. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer. , 2007, Journal of experimental therapeutics & oncology.
[39] Y. Perera,et al. Development and validation of a quantitative ELISA for the measurement of PSA concentration. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[40] N. Zarghami,et al. Association between steroid hormone receptors and PSA gene expression in breast cancer cell lines , 2005 .
[41] M. Eisenstein,et al. Role of galectin-8 as a modulator of cell adhesion and cell growth , 2004, Glycoconjugate Journal.
[42] Pamela Russell,et al. Innovative biomarkers for prostate cancer early diagnosis and progression. , 2010, Critical reviews in oncology/hematology.
[43] Sang Jun Sim,et al. Optical fiber SPR biosensor with sandwich assay for the detection of prostate specific antigen , 2009 .
[44] J. Gu,et al. Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule? , 2010, Clinical Cancer Research.
[45] D. Tenen,et al. Down regulation of PSA by C/EBPα is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell Line , 2006, BMC Cancer.
[46] M. Djamgoz,et al. Citrate transport in the human prostate epithelial PNT2‐C2 cell line: electrophysiological analyses , 2004, The Journal of physiology.
[47] M. Khullar,et al. Anticancer Potential of Aqueous Ethanol Seed Extract of Ziziphus mauritiana against Cancer Cell Lines and Ehrlich Ascites Carcinoma , 2010, Evidence-based complementary and alternative medicine : eCAM.
[48] Yi Lu,et al. Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor , 2005, Clinical & Experimental Metastasis.
[49] K. Tsui,et al. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line. , 2008, Anticancer research.
[50] J. Kang,et al. Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers. , 2005, Biosensors & bioelectronics.
[51] D. Parekh,et al. Biomarkers for prostate cancer detection , 2010, Expert review of anticancer therapy.
[52] Ying Huang,et al. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells. , 2003, Journal of andrology.
[53] P. Nelson,et al. PrLZ, a Novel Prostate-Specific and Androgen-Responsive Gene of the TPD52 Family, Amplified in Chromosome 8q21.1 and Overexpressed in Human Prostate Cancer , 2004, Cancer Research.
[54] T. Heaney. Inhibition of attachment of human gingival fibroblast-like cells in vitro by saliva and salivary-sulfated glycoprotein in the presence of serum. , 1990, Journal of periodontology.
[55] R. Fletterick,et al. Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells , 2011, Proceedings of the National Academy of Sciences.
[56] A. Mostafavi,et al. Synthesis of ZnO nanorods and their application in the construction of a nanostructure-based electrochemical sensor for determination of levodopa in the presence of carbidopa. , 2014, The Analyst.
[57] H. Beitollahi,et al. Electrocatalytic and simultaneous determination of isoproterenol, uric acid and folic acid at molybdenum (VI) complex-carbon nanotube paste electrode , 2011 .
[58] Yong-Hark Jang,et al. Ultra-sensitive surface plasmon resonance based immunosensor for prostate-specific antigen using gold nanoparticle–antibody complex , 2008 .
[59] Sudhir Srivastava,et al. Biomarkers for prostate cancer detection. , 2007, The Journal of urology.
[60] Liesbet Lagae,et al. A simple double-bead sandwich assay for protein detection in serum using UV-vis spectroscopy. , 2011, Talanta.
[61] Juan F Medrano,et al. Real-time PCR for mRNA quantitation. , 2005, BioTechniques.
[62] Chung-Liang Ho,et al. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder. , 2008, Anticancer research.
[63] V. Dolo,et al. Extracellular Vesicles in Prostate Cancer: New Future Clinical Strategies? , 2014, BioMed research international.
[64] Dianqing Wu,et al. Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction , 2006, Molecular and Cellular Biology.
[65] Feng Yu,et al. Electrochemical biosensor based on graphene oxide-Au nanoclusters composites for L-cysteine analysis. , 2012, Biosensors & bioelectronics.
[66] B. Roos,et al. Identification of the human seminal TRH-like peptide pGlu-Phe-Pro-NH2 in normal human prostate , 1994, Peptides.
[67] G. Coetzee,et al. Prostate specific antigen gene regulation by androgen receptor , 2004, Journal of cellular biochemistry.
[68] K. Kihara,et al. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells. , 2004, American journal of physiology. Endocrinology and metabolism.